A study of ATI-502 for the oral treatment of patchy alopecia areata
Latest Information Update: 13 Aug 2018
At a glance
- Drugs Ifidancitinib (Primary)
- Indications Alopecia areata
- Focus Adverse reactions
- 13 Aug 2018 Status changed from planning to recruiting.
- 15 Mar 2017 According to an Aclaris Therapeutics media release, the company plans to submit an investigational new drug (IND) application mid-2017.
- 16 Nov 2016 New trial record